Oragenics
OGEN
10 hedge funds and large institutions have $15.1M invested in Oragenics in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
15% more capital invested
Capital invested by funds: $13.2M → $15.1M (+$1.94M)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more ownership
Funds ownership: 0% → 0% (0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$17.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$17.5K |
OGEN Hedge Fund Activity: Q1 2015 in Review
10 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2015, worth a combined $15.1M — up 15% from $13.2M a quarter earlier.
Fund positioning in OGEN was balanced in Q1 2015: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $17.5K. The largest seller was Bank of America, exiting entirely with an estimated $17.5K sold.
- 10 institutional investors held Oragenics (OGEN) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $15.1M of Oragenics stock for Q1 2015, up 15% quarter-over-quarter.
- 1 fund opened new Oragenics positions in Q1 2015 and 1 closed out, a net change of 0 holders.
- The largest Oragenics buyer in Q1 2015 was Virtu KCG Holdings, an estimated $17.5K added.
- The largest Oragenics seller in Q1 2015 was Bank of America, an estimated $17.5K sold.
Based on aggregated 13F filings for Q1 2015.